Human Umbilical Cord Product Lacks IND, BLA, Company Slapped With Untitled Letter

The FDA sent an untitled letter to Achieve Vitality, which markets a product claiming to offer regenerative therapy, for offering an injectable product derived from human umbilical cord for which the company lacks required regulatory approvals.
Source: Drug Industry Daily